Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma. Stammler R, Ta VA, Cohen E, Ram-Wolff C, et al. Br J Dermatol 2024 Feb 23:ljae085. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stammler R, Ta VA, Cohen E, Ram-Wolff C, et al. Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma. Br J Dermatol 2024 Feb 23:ljae085. doi: 10.1093.
PMID: 38390970